BIA Separations launches purification technology for AAV production
BIA Separations introduces technology able to remove host-cell DNA and proteins from AAV products, aiming to accelerate clinical development of gene therapies.
Archives for September 17, 2019
Lundbeck banks on migraine therapy with $2bn acquisition
Lundbeck agrees to purchase Alder to gain access to its CGRP migraine therapy that looks set to enter a crowded market.
Merz completes construction of new plant and filling line
Merz announces that it has completed the construction of a new plant for its botulinum neurotoxin product and unveils a ‘robot-controlled’ filling line.
GE Healthcare partners to create manufacturing suite for gene therapies
GE Healthcare teams up with Germfree to create a fully integrated, expandable manufacturing solution that is geared towards the development of ‘emerging biotherapeutics’.